7th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 19-21, 2026 | Boston, Massachusetts, USA
Drug-Induced Cognitive Impairments
Drug-induced cognitive impairments occur when substances like alcohol, stimulants, or opioids alter brain function, leading to difficulties in memory, attention, or decision-making. Chronic use disrupts neural pathways, particularly in the prefrontal cortex and hippocampus, responsible for executive functions and memory consolidation. These impairments can hinder daily activities, learning abilities, and social interactions. Cognitive deficits vary by substance and usage patterns but can sometimes persist even after cessation, emphasizing the importance of early intervention. Treatment often includes detoxification, cognitive rehabilitation therapies, and neuroprotective medications to restore brain health. Understanding the mechanisms of drug-induced cognitive impairments aids in developing targeted strategies to mitigate long-term effects and improve the quality of life for affected individuals.
Frederick J Goldstein
Philadelphia College of Osteopathic Medicine, United States
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
John Michael Weber
Trauma Healed Life Coach, United States
Denis Larrivee
University of Navarra, Spain
Steve Cohen
Medvesta Hypnosis Healthcare, United States
Andrew Drasen
A Vision of Hope Media, United StatesSubmit your abstract Today
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College, United States
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Trauma: Till death do us part
John Michael Weber, Trauma Healed Life Coach, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GTI, United States
Title : Beating the blues today
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Reduction of chronic neuropathic pain by a THC-CBD combination capsule: ongoing pilot study
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States